申请人:Bernotas Ronald Charles
公开号:US20120010205A1
公开(公告)日:2012-01-12
Disclosed are quinoline esters of Formula (I):
which are useful as Liver X receptors (LXR) modulators. Pharmaceutical compositions containing quinoline esters of Formula (I) and the use of quinoline esters of Formula (I) in the safe treatment of various skin disorders are also disclosed. Methods for preparing and using quinoline esters are further described.
公开了式(I)的喹啉酯化合物,这些化合物可用作肝X受体(LXR)调节剂。还公开了含有式(I)的喹啉酯化合物的药物组合物,以及在安全治疗各种皮肤疾病中使用式(I)的喹啉酯化合物。进一步描述了制备和使用喹啉酯的方法。